Autoimmune Disease pp 49-51 | Cite as
Immunotherapy
Chapter
First Online:
Abstract
Prednisone is judiciously used, short-term in high dosage and in low dosage for longer term, in the management of various autoimmune diseases [1], including the dangerous vasculitidies and sight-threatening exophthalmos.
Keywords
Systemic Lupus Erythematosus Multiple System Atrophy Bacteriophage Peptide Display Total Lymphoid Irradiation Bone Marrow Grafting
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
References
- 1.Kasper DL, Fauci AS, Longo DL, Braunwald E, Hauser SL, Jameson JL. (eds) Harrison’s Principles of Internal Medicine 16th ed. New York: McGraw-Hill, 2005.Google Scholar
- 2.Eisenberg R. Targeting B cells. In SLE; the experience with Rituximab treatment (anti-CD20). Endocrine, Metabolic and Immune Disorders Drug Targets. 2006;6:345–350.Google Scholar
- 3.Menard HA, El-Amine M. The calpain-calpastatin system in rheumatoid arthritis. Immunol Today. 1996;17:545–7.PubMedCrossRefGoogle Scholar
- 4.Englert H, Katelaris C, McGill N, Schrieber L, Moore J. “Grape-sultana” sign represents a favourable response to aggressive treatment of early diffuse systemic scleroderma. Intern Med J. 2005;35:436–7.PubMedCrossRefGoogle Scholar
- 5.Potter SR, Bienenstock J, Goldstein S, Buchanan WW. Fibroblast growth factors in scleroderma. J Rheumatol. 1985;12:1129–35.PubMedGoogle Scholar
- 6.Xu W, Leroy EC, Smith EA. Fibronectin released by systemic sclerosis and normal dermal fibroblasts in response to TGF-β. J Rheumatol 1991;18:241–246.Google Scholar
- 7.Gilliland BC. Systemic sclerosis. In: Braunwald E, Fauci AS, Kasper DL, Hauser S, Longo Di, Jameson JL. (eds.) Harrison’s Principles of Internal Medicine. 15th ed. New York: McGraw-Hill; 2001;1937–1947.Google Scholar
- 8.Applebaum FR. Hematopoietic cell transplantation. In: Kasper DL, Fauci AS, Longo DL, Braunwald E, Hauser SL, Jamison JL. (eds.) Harrison’s Principles of Internal Medicine. 16th ed. New York: McGraw-Hill; 2005;668-673.Google Scholar
- 9.Adams DD, Knight JG. Principles of autoimmune disease: pathogenesis, genetics and specific immunotherapy. J Clin Lab Immunol. 2003;52:1–22.PubMedGoogle Scholar
- 10.Fisher AJ, Rutherford RM, Bossino J, Parry G, Dark JH, Corris PA. The safety and efficacy of total lymphoid irradiation in progressive bronchiolitis obliterans syndrome after lung transplantation. American J Transplant 2005;5:537–534.Google Scholar
- 11.Adams DD. Seven deficiencies in Harrison’s 16th edition 2005. J Clin Lab Immunol. 2006;54:1–13.Google Scholar
- 12.Smith GP. Filamentous fusion phage: novel expression vectors that display cloned antigens on the virion surface. Science. 1985;228:1315–7.PubMedCrossRefGoogle Scholar
- 13.Scott JK, Smith GP. Searching for peptide ligands with an epitope library. Science 1990;249:386–390.Google Scholar
- 14.McLachlan SM, Rapoport B. The molecular biology of thyroid peroxidase: cloning, expression and role as an autoantigen in autoimmune thyroid disease. Endocrine Reviews 1992;13:192–206.Google Scholar
- 15.Perret J, Ludgate M, Libert F, Vassart G, Dumont J, Parmentier M. Stable expression of the human TSH receptor in CHO cells and characterisation of differentially expressing clones. Biochem Biophys Res Com. 1990;171:1044–50.Google Scholar
- 16.Costagliola S, Morgenthaler N, Hoemann K, Badenhoop K, Dumont J, Vassart G, et al. Second generation assay for TSH receptor antibodies has superior diagnostic sensitivity for Graves; disease. J Clin Endocrinol Metab. 1999;84:90–7.PubMedCrossRefGoogle Scholar
- 17.Wenning GK, Stephania N. Recent developments in multiple system atrophy. J Neurol. 2009;. doi: 10.1007/s00415-5173-8.PubMedGoogle Scholar
Copyright information
© The Author(s) 2013